Philips: partners with Merck in personalized fertility
(CercleFinance.com) - Dutch health-technology company Philips on Thursday announced a multi-year partnership with US pharmaceuticals giant Merck to develop digital solutions for personalized fertility treatment.
Under the deal, the companies will use digital health technologies, advanced informatics and mobile, and AI-based ultrasound diagnostics, to help aspiring parents maximize the chances of conception.
"We believe that the future of in vitro fertilization will be unlocked through digital health technologies that empower professionals and patients to be better connected," Merck said.
Philips said the partnership will build on its expertise in maternal and foetal monitoring, consumer engagement apps, ultrasound solutions and its cloud/AI platforms.
Copyright (c) 2021 CercleFinance.com. All rights reserved.